The basolateral amygdala (BLA) plays crucial roles in stimulus value coding, as well as drug and alcohol dependence. Ethanol alters synaptic transmission in the BLA, while endocannabinoids (eCBs) produce presynaptic depression at BLA synapses. Recent studies suggest interactions between ethanol and eCBs that have important consequences for alcohol drinking behavior. To determine how ethanol and eCBs interact in the BLA, we examined the physiology and pharmacology of GABAergic synapses onto BLA pyramidal neurons in neurons from young rats. Application of ethanol at concentrations relevant to intoxication increased, in both young and adult animals, the frequency of spontaneous and miniature GABAergic inhibitory postsynaptic currents, indicating a presynaptic site of ethanol action. Ethanol did not potentiate sIPSCs during inhibition of adenylyl cyclase while still exerting its effect during inhibition of protein kinase A. Activation of type 1 cannabinoid receptors (CB1) in the BLA inhibited GABAergic transmission via an apparent presynaptic mechanism, and prevented ethanol potentiation. Surprisingly, ethanol potentiation was also prevented by CB1 antagonists/inverse agonists. Brief depolarization of BLA pyramidal neurons suppressed GABAergic transmission (depolarization-induced suppression of inhibition [DSI]), an effect previously shown to be mediated by postsynaptic eCB release and presynaptic CB1 activation. A CB1-mediated suppression of GABAergic transmission was also produced by combined afferent stimulation at 0.1 Hz (LFS), and postsynaptic loading with the eCB arachidonoyl ethanolamide (AEA). Both DSI and LFS-induced synaptic depression were prevented by ethanol. Our findings indicate antagonistic interactions between ethanol and eCB/CB1 modulation at GABAergic BLA synapses that may contribute to eCB roles in ethanol seeking and drinking. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
The basolateral amygdala (BLA) plays key roles in value coding, effect, and actions of abused drugs, including conditioned place preference for ethanol and other substances (Brown & Fibiger, 1993; Davis, Rainnie, & Cassell, 1994; Everitt, Morris, O'Brien, & Robbins, 1991; Gremel & Cunningham, 2009; Hiroi & White, 1991; LeDoux, 1993 LeDoux, , 2000 Olmstead & Franklin, 1997; Sarter & Markowitsch, 1985; See, Fuchs, Ledford, & McLaughlin, 2003; Stuber et al., 2011) . The BLA is also implicated in ethanol withdrawal-induced increases in anxiety, as well as other withdrawal/abstinencerelated behaviors (Läck, Christian, Diaz, & McCool, 2009; Läck, Diaz, Chappell, DuBois, & McCool, 2007) . Acute ethanol exposure alters BLA neuron excitability and increases GABAergic synaptic transmission onto BLA projecting neurons, including increasing GABA release at synapses made by local interneurons (Silberman, Ariwodola, & Weiner, 2009; Silberman, Shi, Brunso-Bechtold, & Weiner, 2008; Zhu & Lovinger, 2006) . GABAergic transmission at interneuron synapses onto BLA projection neurons is also altered after chronic ethanol exposure . It is important to elucidate ethanol actions in BLA to gain a better understanding of the basis of cellular and circuitlevel effects of this drug.
Presynaptic, Gi/o-interacting G-protein-coupled receptors (GPCRs) inhibit neurotransmitter release and prevent ethanol effects at GABAergic synapses in several brain regions (Ariwodola & Weiner, 2004; Kang-Park, Kieffer, Roberts, Siggins, & Moore, 2007; Kelm, Criswell, & Breese, 2008; Offermanns, 2003; Roberto et al., 2010; Silberman et al., 2009; Theile, Morikawa, Gonzales, & Morrisett, 2008; Wan, Berton, Madamba, Francesconi, & Siggins, 1996; Zhu & Lovinger, 2006) , suggesting that endogenous neurotransmitter actions limit ethanol-induced increases in release. A possible point of convergence for the ethanol and Gi/o-GPCRs is adenylyl cyclase (AC). This cyclic AMP-generating enzyme can be activated by ethanol (Tabakoff, Nelson, Yoshimura, Hellevuo, & Hoffman, 2001 ) and inhibited by the GPCRs of interest. Determining which neurotransmitters produce these ethanol potentiation-limiting effects at which synapses will help us to understand acute drug actions under different physiological conditions.
Cannabinoid type 1 (CB1) receptors are predominantly presynaptic and decrease neurotransmitter release (Freund, Katona, & Piomelli, 2003; López-Moreno, González-Cuevas, Moreno, & Navarro, 2008; Mackie, 2008; Matsuda, Bonner, & Lolait, 1993; Wilson & Nicoll, 2001 ). CB1 expression is robust in the BLA, and strongly localized to axon terminals of CCK-expressing GABAergic interneurons (Katona et al., 2001) . Endocannabinoids (eCBs), endogenous lipid metabolites, activate CB1 receptors (Alger, 2009) . Arachidonoyl ethanolamide (AEA) and 2-arachidonoyl glycerol (2-AG) are the best characterized eCBs (Heifets & Castillo, 2009 ). Receptor activation by eCBs usually involves "retrograde" postsynaptic-to-presynaptic signaling that produces either shortor long-term synaptic depression (Alger, 2009; Alger et al., 1996; Heifets & Castillo, 2009; Lovinger, 2007 Lovinger, , 2008 Ohno-Shosaku, Maejima, & Kano, 2001; Wilson & Nicoll, 2001) , both of which have been observed at GABAergic synapses onto BLA principal neurons (Marsicano et al., 2002; Patel, Kingsley, Mackie, Marnett, & Winder, 2009; Szabo & Schlicker, 2005; Zhu & Lovinger, 2005) . The eCB-mediated reduction of GABA release enhances excitatory output from BLA (Perra, Pillolla, Luchicchi, & Pistis, 2008) .
Past studies have described interactions between eCB/CB1 signaling and acute ethanol effects, in which CB1 activation depresses GABAergic transmission and prevents ethanol potentiation of GABA release (Kelm et al., 2008; Roberto et al., 2010) . Signaling by eCBs is also implicated in behavioral actions of ethanol, including intake and preference, as well as conditioned place preference (Alén et al., 2009; Arnone et al., 1997; Basavarajappa, Ninan, & Arancio, 2008; Basavarajappa, Yalamanchili, Cravatt, Cooper, & Hungund, 2006; Blednov, Cravatt, Boehm, Walker, & Harris, 2007; Cippitelli et al., 2005 Cippitelli et al., , 2007 Colombo et al., 2007; Colombo, Serra, Vacca, Carai, & Gessa, 2005; Economidou et al., 2006; Freedland, Sharpe, Samson, & Porrino, 2001; Houchi et al., 2005; Hungund & Basavarajappa, 2000 Manzanares, Ortiz, Oliva, Pérez-Rial, & Palomo, 2005; Pava et al., 2012; Thanos, Dimitrakakis, Rice, Gifford, & Volkow, 2005; Vinod, Sanguino, Yalamanchili, Manzanares, & Hungund, 2008; . Chronic ethanol treatment produces tolerance to the behavioral effects of cannabinoids (Pava et al., 2012) . This evidence suggests important eCB roles in regulation of the CNS effects of ethanol.
In the present study, we examine interactions between ethanol and eCB/CB1 signaling at GABAergic synapses in rat BLA. In addition, studies have indicated that adolescent rats are less sensitive than adults are to several ethanol actions in both electrophysiological and behavioral experiments (Little, Kuhn, Wilson, & Swartzwelder, 1996; Silveri & Spear, 1998; Van Skike et al., 2010) . Administration of low to moderate ethanol doses induces social facilitation in young animals, while the same doses reduce social behavior in adults (Varlinskaya & Spear, 2002) . The different response to ethanol in adolescents may play an important role in the development of ethanol-related problems (Spear & Varlinskaya, 2005) . For this reason, we evaluated, in a separate set of adult animals, some of the effects observed in young rats regarding the interaction between ethanol and the eCB system. Our findings indicate a general antagonistic effect between ethanol and cannabinoidergic transmission that has strong implications for acute intoxication.
Materials and methods

Brain slice preparation
All experiments were approved by the NIAAA Animal Care and Use Committee. Postnatal day 15e19 (young) or day 50e60 (adult) Sprague Dawley rats were anesthetized by halothane inhalation. After trans-cardial perfusion with ice-cold modified artificial cerebrospinal fluid (aCSF) containing (in mM): 194 sucrose, 30 NaCl, 4.5 KCl, 1 MgCl 2 , 26 NaHCO 3 , 1.2 NaH 2 PO 4 , and 10 glucose (pH 7.4 with 95% O 2 /5% CO 2 ), they were then decapitated, and their brains rapidly transferred into ice-cold modified aCSF. Coronal sections (300 mm thickness) were cut in ice-cold modified aCSF using a Leica VT1200S vibratome (Leica Microsystem Nussloch GmbH, Heidelberg, Germany). Slices were transferred immediately to a nylon net submerged in normal aCSF containing (in mM): 124 NaCl, 4.5 KCl, 2 CaCl 2 , 1 MgCl 2 , 26 NaHCO 3 , 1.2 NaH 2 PO 4 , and 10 D-glucose, with osmolarity set to 320 mOsm (pH 7.4), at 33 C for at least 30 min. After an additional 1-h incubation at room temperature, hemislices were transferred to a recording chamber, submerged in normal aCSF with a constant flow of w2 ml/min. For all experiments, the temperature of the bath was maintained at w31 C during any given experiment.
Neuronal isolation
Mechanical isolation of BLA neurons was performed as previously described (Jun, Cuzon Carlson, Ikeda, & Lovinger, 2011; Zhu & Lovinger, 2005) . Briefly, coronal brain slices containing BLA were transferred to a 35-mm diameter culture dish containing (in mM) 150 NaCl, 5 KCl, 10 HEPES, 1 MgCl 2 , 2.5 CaCl 2 , 10 D-glucose, pH adjusted to 7.4 using NaOH, osmolarity set to w300 mOsm with sucrose. Using a piezoelectric bimorph (Burleigh Instruments, NY), the tip of a flame-sealed micropipette was vibrated laterally at 30 Hz as it descended through the BLA. The slice was then removed from the dish, leaving the isolated neurons.
Whole-cell voltage-clamp recording
In brain slices, whole-cell recordings were performed from BLA principal neurons. Recording pipettes were pulled from borosilicate glass on a Flaming Brown micropipette puller (Novato, CA). Pipette resistance ranged from 2.5 to 4.5 MU, when filled with a CsCl-based internal solution containing (in mM): 150 CsCl, 10 HEPES, 5 lidocaine N-ethyl bromide (QX314), 2 MgCl 2 , 3 Mg-ATP, 0.3 Na-GTP, and 0.2 BAPTA-4K, pH adjusted to 7.2 with CsOH, and osmolarity set to 298 mOsm with sucrose. To exclude the presence of glutamatergic synaptic responses, 50 mM AP5 and 5 mM NBQX were added to the solution to block NMDA and AMPA receptor-mediated currents, respectively. Cells were voltage-clamped at À60 mV. We analyzed only recordings with series resistance values ranging from 9 to 25 MU without compensation, and if this value changed by more than 20% during the course of an experiment, the cell was discarded.
Synaptic currents were recorded with an Axopatch 700A amplifier (Axon Instruments, Foster City, CA), filtered at 2 kHz, and digitized at 5 kHz. Spontaneous IPSC amplitude and frequency were measured using peak and event detection software in pCLAMP9.2 and analyzed by Minianalysis software (Synaptosoft, Decatur, GA, USA). After initiation of the whole-cell recording, stable baseline responses were observed within w10 min. After 2e3 additional minutes of baseline recording, we started drug perfusion or the DSI protocol. For evoked IPSC recordings, the concentric bipolar stimulating electrode was placed approximately 200 mm medial to the recording site. This would certainly stimulate the inhibitory afferents arising from local interneurons, but stimulation of afferents from paracapsular cells cannot be ruled out. For DSI experiments, after a recording period of approximately 3 min, the membrane potential was stepped from À60 to 0 mV for 5 s under voltage clamp. The magnitude of DSI was calculated as the sIPSC amplitude and frequency after the depolarization divided by the average during a 3-min pre-depolarization period. In a different set of experiments, AEA (50 mM) was loaded in the patch electrode to increase the pool of endocannabinoid available for release during DSI. The low-frequency stimulation (LFS) protocol consisted of 0.1-Hz stimulation for 3 min using a concentric bipolar electrode (FHC, Bowdoin, ME). Stimulation intensity was set to induce an eIPSC with an amplitude w50% of the maximal response.
In some experiments examining ethanol effects on DSI, the DSI protocol was repeated three times in each neuron, once during the baseline period, once in the presence of ethanol, and once after washout. In other experiments the DSI protocol was run only once per cell, and SR or ethanol were present throughout the recording. In the experiments involving ethanol wash-on and washout, we applied the DSI protocol after 3 min of stable baseline and continued to record for an additional 3 min after DSI. We then applied ethanol to the slice for a total of 5 min. Three minutes into the ethanol application, if the response was stable, we applied the DSI protocol again. Two minutes after this second DSI protocol, we began the washout of ethanol. After a total of 4 min of washout, we again applied the DSI protocol, and recorded for a further 3 min. Whole-cell voltage-clamp recordings from isolated neurons were performed on the stage of an inverted Nikon T200 microscope as previously described (Zhu & Lovinger, 2006) , using micropipettes with resistances of 2e4 MU filled with the CsCl-based solution. Solutions containing ethanol and other compounds were applied via local perfusion using an array of fused square-tipped glass tubes, with lateral movement driven by the Faststep stepper motor system (Warner Instruments, Hamden, CT). Recordings were performed in the presence of 5 mM NBQX and 25 mM AP5 to block fast glutamatergic transmission, allowing for measurement of spontaneous GABA A receptor-mediated IPSCs.
Drugs
The following drugs were used: ethanol (Pharma corporation), WIN 55,212, SR161417A, AEA, 2AG, H-89, BSE, and DDA (SigmaeAldrich, San Diego, CA), NBQX, D-AP5, TTX (Tocris, Ellisville, MO).
Statistical analysis
Statistical comparisons of pooled data were performed by t test, or one-way ANOVA followed by the Tukey or Neuman-Keuls post hoc tests, or repeated-measures two-way ANOVA. In all cases, a p value of <0.05 was considered statistically significant.
Results
Effect of ethanol on sIPSCs recorded from BLA principal neurons of young rats
GABAergic sIPSCs occur with reliable frequency and amplitude (Ampl. 56.3 AE 6 pA; Freq. 8.4 AE 0.8 Hz; n ¼ 73) in pyramidal neurons examined in BLA brain slices ( Fig. 1 ) from young rats, as previously reported (Diaz, Chappell, Christian, Anderson, & McCool, 2011; Silberman et al., 2008; Zhu & Lovinger, 2006) . Consistent with previous studies (Silberman et al., 2009; Zhu & Lovinger, 2006) , application of 80 mM ethanol induced a significant increase in sIPSC amplitude and frequency that developed within 3e4 min of the onset of ethanol application (Amp: 32 AE 12% increase; Freq: 56 AE 12% increase; p < 0.05, paired t test), (Fig. 1AeC) . The potentiation reversed within 5 min after cessation of ethanol application. Potentiation of sIPSC frequency by ethanol was concentrationdependent (F[4,58] ¼ 3.89, p ¼ 0.007), without any significant concentration-dependence of the change in event amplitude, where only the higher concentrations were significant (p < 0.05, paired t test) ( Fig. 1D and E) . In another set of neurons from young rats, we examined action potential-independent miniature IPSCs (mIPSCs) in the presence of the voltage-dependent sodium channel blocker TTX (1 mM) (basal amplitude 45.3 AE 6.2 pA; basal frequency 4 AE 0.9 Hz; n ¼ 11). When ethanol (80 mM) was perfused into the slice it increased mIPSC frequency by 41 AE 18% (p < 0.05, paired t test vs. control) without any significant change in amplitude (15 AE 8.5%), (Fig. 1F and G) .
Effect of adenylyl cyclase and PKA inhibitors on ethanol potentiation of sIPSCs
Previous studies evaluated the adenylyl cyclase (AC) and protein kinase A (PKA) effect on ethanol potentiation of GABA release (Kelm et al., 2008; Roberto et al., 2010) . Ethanol can activate AC (Luthin & Tabakoff, 1984; Rabin & Molinoff, 1981) , and we thus examined effects of AC activation and inhibition, as well as PKA inhibition, on GABAergic sIPSCs and ethanol potentiation in BLA slices from young animals. As previously described in hippocampus (Chevaleyre, Heifets, Kaeser, Südhof, & Castillo, 2007) and prefrontal cortex (Chiu, Puente, Grandes, & Castillo, 2010) , a 30-min pre-incubation with the 10 mM AC inhibitor dideoxy-adenosine (DDA) or the PKA inhibitor H-89 (10 mM) decreased basal sIPSC frequency without affecting amplitude (Fig. 2AeC ). Bath application of the AC activator forskolin (10 mM) potentiated sIPSC frequency. The forskolin effect was prevented by previous incubation of slices in 10 mM DDA ( Fig. 2D and E). The increases in sIPSC amplitude and frequency induced by 80 mM ethanol were reduced in slices incubated with DDA ( Fig. 2F ), as previously reported (Kelm et al., 2008) . However, in slices treated with H-89, ethanol was still able to induce an increase in sIPSC frequency that was not distinguishable from the effect of ethanol alone (Fig. 2F) . A significant difference among the three treatment groups in ethanol effects on sIPSC amplitude was observed (one-way ANOVA, F[2,14] ¼ 8.28, p ¼ 0.0042), with post hoc Tukey multiple comparisons indicating significant differences only between the ethanol alone and DDA þ ethanol treatments. Analysis of the sIPSC frequency data indicated a significant effect of treatment (F[2,14] ¼ 7.004, p ¼ 0.0078), with post hoc comparisons indicating significant differences only between the ethanol alone versus DDA þ ethanol group. One-sample t tests indicated that ethanol produced significant increases in sIPSC frequency in all groups, and thus DDA did not completely eliminate ethanol potentiation of GABAergic transmission.
CB1R interactions with ethanol-induced increases in GABA release
We next determined whether CB1 receptor activation alters synaptic transmission and ethanol potentiation at GABAergic terminals in BLA principal neurons recorded from brain slices made from young animals, as has been observed at other synapses (Roberto et al., 2010) . The CB1 agonist WIN 55,212 (WIN) (5 mM) significantly decreased sIPSC frequency (35.7 AE 7% below baseline, p < 0.01), but not amplitude (6.7 AE 4.4) ( Fig. 3A and B ). Once sIPSC frequency had reached a stable level in the presence of WIN, we applied 80 mM ethanol in the continued presence of CB1 agonist. No significant change in sIPSC frequency or amplitude was observed during ethanol (80 and even 150 mM) application in the presence of WIN (Fig. 3C and D) (p > 0.05, t test vs. baseline).
We next evaluated the effect of ethanol in the presence of the CB1 antagonist/inverse agonist SR141716A (SR) (1 mM) in the slice preparation. The compound was applied for 3 min prior to 5-min co-application of ethanol (80 mM), and SR did not alter sIPSC (10, 25, 50, 80, and 150 mM) . The extent of the ethanol effect was calculated during the 2 min in which the drug showed its maximal effect. Data are expressed as mean AE SEM (n ¼ 5, 9, 11, 27, and 11 cells, respectively). F) Bar graph showing 80-mM ethanol effects on amplitude and frequency of TTX-insensitive sIPSCs (mIPSCs) (n ¼ 11 cells) (*p < 0.05 vs. baseline, paired t test). G) Representative traces of mIPSCs recorded from a single neuron before, during, and after ethanol slice perfusion (scale bar 50 pA, 5 s). amplitude or frequency, but prevented the increase induced by ethanol (Fig. 3EeG) (p < 0.05 vs. baseline, t test). The increase in sIPSC frequency induced by 80 mM ethanol was intact in the presence of DMSO (dimethyl sulfoxide, 0.01%), the carrier used to dilute SR (Amp: 27.6 AE 4.8%, Freq: 56.9 AE 6.5% increase; data not shown). Another CB1 antagonist/inverse agonist, AM251 (1 mM) also prevented ethanol (80 mM) potentiation of sIPSC frequency and amplitude (amp ¼ 0.57 AE 1.3%, paired t test, p > 0.05, freq ¼ 2.3 AE 4.6%, paired t test, p > 0.05, n ¼ 11). However, when a high concentration of ethanol (150 mM) was used, SR did not reduce ethanol potentiation of sIPSC frequency (paired t test, (Fig. 3H) .
In mechanically isolated BLA principal neurons from young animals, we observed sIPSCs, and application of 80-mM ethanol increased sIPSC amplitude and frequency (Fig. 4A, C, D) (p < 0.05 vs. baseline, t test), consistent with our previous observations (Zhu & Lovinger, 2005) . In a separate set of neurons we applied SR (1 mM) throughout the recording. Similar to what was observed by Zhu and Lovinger (2005) , SR perfusion induced an increase in sIPSC frequency of 52 AE 20% above baseline in 58% (4 of 7) of cells tested. However, no potentiation was observed in the remaining cells. In the presence of SR, ethanol 80 mM failed to increase the frequency and amplitude of sIPSCs (Fig. 4BeD) . Thus, the ability of the CB1 antagonist/inverse agonist to prevent potentiation by ethanol is not dependent on intact circuitry or the slice milieu, and is likely due to a more direct effect on ethanol-sensitive axon terminals.
Ethanol reduces DSI at synapses on BLA principal neurons
To determine if ethanol alters eCB actions at BLA GABAergic synapses, we first examined depolarization-induced suppression of Forskolin (20 mM) increased sIPSC frequency, and this effect was dramatically decreased in slices incubated for 30 min with DDA. Representative current traces in D show forskolin effects on sIPSCs in the absence (top) and presence (bottom) of DDA. Scale bar ¼ 50 pA, 10 s. Bar graphs in E show the forskolin and forskolin þ DDA effects on sIPSC amplitude and frequency (n ¼ 5, 3) (*p < 0.05 vs. baseline paired t test; #p < 0.05 vs. forskolin, unpaired t test). F) The AC inhibitor DDA decreases ethanol potentiation of the amplitude and frequency of sIPSCs recorded from BLA-projecting neurons, while the PKA inhibitor H-89 did not significantly alter ethanol actions (n ¼ 27, 7, 5) (*p < 0.05 vs. baseline, paired t test). inhibition (DSI) in slices from young rats. Depolarization of the pyramidal neuron from À60 to 0 mV for 5 s induced a fast-onset, transient (15e20 s post-depolarization duration) decrease in sIPSC frequency (25.7 AE 2.7% below baseline, p < 0.01 paired t test, n ¼ 45) (Fig. 5A and B) , as observed in previous studies (Patel et al., 2009; Zhu & Lovinger, 2006) . Application of 50 or 80 mM ethanol for 3 min increased sIPSC frequency as previously observed (% increase ¼ 28 AE 5.1 at 50 mM, 33 AE 13.6 at 80 mM), while 25 mM ethanol had no effect. In the pre-ethanol baseline condition, postsynaptic depolarization produced significant sIPSC frequency depression ( Fig. 5B and C) (p < 0.05 vs. baseline, t test). As shown in Fig. 5B and C, application of different concentrations of ethanol reduced the depolarization-induced decrease in sIPSC frequency (repeated-measures two-way ANOVA, significant treatment effect F [1,30] ¼ 23.1, p < 0.05), with no significant effect of ethanol concentration or significant interaction. No significant decrease in sIPSC frequency was observed following depolarization in the presence of the 50 or 80 mM concentrations (Fig. 5C ). This decrease in DSI was reversed when ethanol was removed from the preparation (Fig. 5C) , indicating that the loss of sIPSC depression was not due to a time-dependent loss of DSI. The depolarization protocol did not alter sIPSC amplitude in the absence or presence of ethanol (Fig. 5D ) (p > 0.05, two-way ANOVA).
To try to enhance DSI magnitude, and perhaps bypass ethanol effects on eCB synthesis, we filled the patch electrode with AEA (10 mM) or 2-AG (10 mM) and applied the depolarization protocol in these eCB-loaded cells. The magnitude and time course of DSI were unchanged in neurons filled with AEA relative to neurons filled with the standard internal solution containing CsCl (Fig. 5B, E, F) . We obtained the same result filling the recording electrode with 2-AG (decrease in sIPSC freq. following DSI ¼ 36.8 AE 6.6 below baseline). Bath application of the CB1 antagonist/inverse agonist SR (1 mM) prevented DSI in AEA-loaded cells ( Fig. 5E and F) . Bath application of 80 mM ethanol prevented DSI in the AEA-loaded cells, as observed in the non-loaded neurons ( Fig. 5E and F) , (F [3,45] ¼ 11.43, p < 0.05). This finding suggests that the effects of ethanol are not via inhibition of eCB synthesis.
Effect of ethanol and CB1 agonist in adult rats
The effects of ethanol and CB1 agonists on GABAergic synapses might be dependent on the developmental stage of animals tested, as previous studies have indicated such changes over development in other brain regions and in behavioral tests (Little et al., 1996; Silveri & Spear, 1998; Van Skike et al., 2010) . As observed in young rats, GABAergic sIPSCs occur with reliable frequency and amplitude in BLA principal neurons from adults (Ampl. 38.86 AE 3.14 pA; Freq. 3.31 AE 0.38 Hz; n ¼ 26). Application of 80 mM ethanol induced a significant increase in sIPSC amplitude and frequency recorded in BLA slices from adult animals, similar to what was observed in young rats (Amp: 27.8 AE 3.38% increase; Freq: 37.8 AE 9.6% increase; p < 0.05 one-sample t test vs. baseline) (Fig. 6AeD) . As previously observed, the potentiation reversed within 5 min after cessation of ethanol application. To evaluate the interaction between ethanol and eCB, we first examined ethanol actions in the presence of the CB1 agonist. As observed in young rats, WIN 55,212 (5 mM) decreased sIPSC frequency (65.4 AE 6.2% below baseline, p < 0.001) (Fig. 7A ) without any change in sIPSC amplitude (data not shown). After sIPSC frequency had reached a stable level in the presence of WIN, we applied 80-mM ethanol in the continued presence of CB1 agonist. Even in adult animals, no significant change in sIPSC frequency was observed during ethanol application in the presence of WIN (Fig. 7A and B) (p < 0.05 vs. baseline, t test). To determine whether ethanol alters eCB actions at GABAergic synapses in neurons from adult animals, we used the DSI protocol. DSI induced a decrease in sIPSC frequency (40.61 AE 6.42% below baseline, p < 0.01 paired t test, n ¼ 4) (Fig. 7C) during the first 15 s after cessation of the depolarization step. Application of 80-mM ethanol significantly reduced the magnitude of the decrease in sIPSC frequency induced by the DSI protocol, and the effect of DSI recovered completely after a 5e10-min ethanol washout (Fig. 7C and D) (p < 0.05 vs. baseline, t test), indicating that the loss of sIPSC depression was not due to a time-dependent loss of DSI. 
Ethanol prevents eCB-mediated synaptic depression induced by low-frequency afferent activation
We combined afferent stimulation with postsynaptic loading of AEA in neurons from young animals, in the presence of NBQX (5 mM) and APV (50 mM), to determine whether we could produce CB1-dependent synaptic depression while bypassing mechanisms involved in eCB production. Afferent stimulation at 0.1 Hz (LFS) for 3 min induced a significant decrease in sIPSC frequency that persisted for over 3 min following cessation of stimulation in recordings from AEA-filled BLA pyramidal neurons ( Fig. 8A and B) . In cells filled only with the CsCl-based pipette solution, LFS did not alter sIPSC frequency (Fig. 8A and B) . The decrease in sIPSC frequency observed with LFS plus AEA loading (10 mM) was prevented by SR ( Fig. 8C and D) , consistent with previous observations in striatum that combined synaptic activation and postsynaptic eCB loading induce CB1-dependent synaptic depression (Adermark & Lovinger, 2009; Ronesi & Lovinger, 2005) . LFS failed to alter sIPSC frequency in AEA-loaded neurons in the presence of 80 mM ethanol ( Fig. 8E and F) . One-way ANOVA indicated significant differences across conditions (F[3,140] ¼ 26.6, p < 0.05), and post hoc analyses with the Neuman-Keuls Multiple Comparison Test revealed significant differences (p < 0.05) in the AEA vs. CsCl alone-loaded comparison, the AEA vs. AEA þ SR comparison, and the AEA vs. AEA þ ethanol comparison, but not in other comparisons. These findings indicate that ethanol inhibits eCB-mediated synaptic depression and likely does so at a step that occurs after eCB synthesis, as the depression we observed only occurred at synapses onto eCB-loaded neurons.
Discussion
The present study indicates that ethanol interacts with the BLA eCB/CB1 signaling system in several ways. Strong activation of the CB1 receptor prevents ethanol potentiation of GABA release, consistent with previous studies (Perra et al., 2008; Roberto et al., 2010) , and consistent with other studies indicating that several Gi/o-coupled GPCRs prevent presynaptic ethanol actions in BLA and elsewhere (Ariwodola & Weiner, 2004; Kang-Park et al., 2007; Kelm et al., 2008; Roberto et al., 2010; Silberman et al., 2009; Wan et al., 1996; Zhu & Lovinger, 2006) . Importantly, we observed that ethanol interactions with eCB/CB1 signaling are not only confined to young animals but are also present in the adult. Thus, developmental changes in ethanol sensitivity that have been noted in other brain regions and in behavioral tests (Little et al., 1996; Silveri & Spear, 1998; Van Skike et al., 2010) do not appear to be occurring at BLA GABAergic synapses. The opposing ethanol and GPCR actions may involve AC, as ethanol is known to potentiate the function of certain ACs (Rabin & Molinoff, 1981; Tabakoff et al., 2001) , while Gi/oa subunits liberated by receptor activation are AC inhibitors (Davis, Ronesi, & Lovinger, 2003; Freund et al., 2003; Wartmann, Campbell, Subramanian, Burstein, & Davis, 1995) . Our findings indicate that AC inhibition interferes with ethanol potentiation of GABA release, supporting a role for this signaling system in ethanol actions. Interestingly, PKA inhibition did not appear to alter ethanol actions as effectively as did AC inhibition. This might indicate a role for increased cAMP independent of PKA activation. It is not yet known how these signaling pathways are recruited in vivo, and how they may alter ethanol-related behaviors. The ability of CB1 agonists to prevent ethanol potentiation of GABAergic transmission has implications for the effect of combined ethanol and synthetic or phytocannabinoid use. The cannabinoid drugs appear to be able to suppress this ethanol action, adding another layer of complexity to the interactions of these often co-abused substances that must be kept in mind when examining interactions in vivo.
Surprisingly, CB1 antagonists/inverse agonists also reduced ethanol potentiation in both brain slices and isolated neurons. It is odd that both agonists and antagonists/inverse agonists have the same action. Perhaps CB1 receptors are constantly activated by tonic eCB signaling that would produce a tone of AC inhibition. The antagonist/inverse agonist could relieve this tone, and might then occlude ethanol potentiation. This scenario seems unlikely, given that no increase in sIPSC frequency, indicative of relief of the tone, was observed during CB1 antagonist/inverse agonist application in BLA slices. Another possibility is that ethanol potentiation involves, at least in part, actions on the CB1 receptor or proximal signaling molecules such as the G protein itself. In this case, strong receptor activation would counteract ethanol actions while receptor occupancy with an inverse agonist might also render the receptor or G protein insensitive to other modulators. The SR prevention of ethanol actions in the neuron/synaptic bouton preparation supports the idea that the site of interaction is located at the synaptic terminal itself. A high ethanol concentration was effective in potentiating GABA release in the presence of SR, indicating that the antagonist/inverse agonist effect can be overcome if the alcohol effect is sufficiently strong. This finding may provide a clue as to how prevention of ethanol effects differs when CB1 is occupied by different ligands. Our findings are similar to the observation in hippocampus by Basavarajappa et al. (2008) , who showed antagonism between SR and ethanol effects on glutamate release as well as in BLA by Perra et al. (2008) , but differ from those in previous studies that examined effects of GPCR blockade on ethanol potentiation of GABA release (Silberman et al., 2009 ), including a study in which CB1 antagonist/inverse agonist treatment did not interfere with ethanol potentiation in central amygdala (Roberto et al., 2010) . It is likely that the interactions between ethanol and eCB/CB1 signaling are more complex in BLA than in other brain regions, as our findings with DSI-and LFS-induced synaptic depression (discussed below) suggest.
While the observation that ethanol interacts with CB1 receptor function is not new when considering findings from other brain regions, acute ethanol interactions with synaptic signaling by endocannabinoids has not been explored. This set of experiments is crucial for understanding the full range of effects that ethanol will have on this neuromodulatory system in the intact nervous system. Thus, we examined ethanol effects on DSI, and observed a reversible prevention of the decrease in GABA release normally induced by postsynaptic depolarization in the DSI protocol. This action may actually override any effects of CB1 activation on ethanol potentiation of GABAergic synaptic transmission (i.e., those observed with exogenous agonist application as in Figs. 3, 4 and 7) . It appears that, in the presence of ethanol, the endocannabinoid is either not released or cannot activate CB1 receptors, and this action would have the net effect of maintaining strong GABAergic transmission under conditions when it would normally be suppressed. The combined potentiation of GABAergic transmission and DSI suppression by ethanol has the potential to suppress BLA output quite strongly. There are several mechanisms through which ethanol might alter endocannabinoid modulation of GABA release, and we explored some of these possibilities with additional experiments. Ethanol prevented DSI even when the postsynaptic neuron was loaded with AEA during the experiment, suggesting that increasing the eCB available for release could not overcome the ethanol effect. It must be noted, however, that postsynaptic AEA loading did not alter DSI magnitude, and thus we cannot be confident that this treatment enhances eCB signaling under this experimental condition. Application of LFS to activate transmission onto AEA-loaded BLA neurons induced depression of sIPSC frequency. This synaptic depression resembles effects of postsynaptically loaded eCBs previously observed in striatum and hypothalamus (Adermark & Lovinger, 2009; Gerdeman, Ronesi, & Lovinger, 2002; Jo, Chen, Chua, Talmage, & Role, 2005; Ronesi & Lovinger, 2005) . As observed with DSI, ethanol prevented the LFS/ loading-induced synaptic depression. The ability of ethanol to prevent eCB/CB1-mediated synaptic plasticity at GABAergic BLA synapses is likely due to interference with eCB release or presynaptic signaling. It seems unlikely that interference with eCB synthesis accounts for these actions, as there is ample AEA available in the LFS/AEA-loading experiment. Given the ethanol potentiation of GABA release, the interference with eCB-retrograde signaling by this drug might be due to increased probability of GABA release that counteracts the ability of CB1 to inhibit this process in both young and adult rats. However, the experiments examining CB1 agonist interactions with ethanol suggest that the interpretation is not so simple, as agonist-induced synaptic depression is clearly intact during ethanol exposure (Fig. 3B) .
Ethanol blockade of eCB retrograde signaling and antagonist/ inverse agonist prevention of ethanol potentiation may be related. Ethanol may interfere with CB1/G protein signaling when receptors are occupied by a partial agonist like AEA, but this effect might be reduced in the presence of an antagonist/inverse agonist and eliminated altogether when a full agonist acts on the receptor. Regardless of the molecular mechanisms involved, our findings indicate complex antagonistic interactions between ethanol and eCB/CB1 signaling that may differ when ethanol is the only drug ingested or when a CB1 agonist is also present.
Consistent with previous studies, we observed that ethanol increases GABAergic synaptic transmission via apparent presynaptic mechanisms in brain slices and the "neuron/synaptic bouton" preparation from BLA, supporting the idea that ethanol actions take place at the axon terminal itself (Lovinger & Roberto, 2013; Roberto, Madamba, Moore, Tallent, & Siggins, 2003; Silberman et al., 2009; Zhu & Lovinger, 2006) . It is tempting to speculate that this may occur mainly at synapses made by local, as opposed to intercalated, BLA interneurons, given the finding that presynaptic ethanol potentiation mainly occurs at local-circuit synapses (Silberman et al., 2009) . It is known that CB1 receptors are expressed by CCKpositive local interneurons in the basal and lateral amygdala, most likely on synaptic terminals (Katona et al., 2001 ). This study and physiological evidence from Geracitano, Kaufmann, Szabo, Ferraguti, and Capogna (2007) indicate that CB1 receptors are not present or functional on paracapsular synapses onto BLA principal neurons. These findings support the idea that the ethanol-eCB/CB1 interactions we have observed mainly involve local interneuron synapses. However, we did not directly evaluate the cellular origin of the affected synapses in this study. Similar acute ethanol effects have now been observed repeatedly at GABAergic synapses in many brain regions (Kelm, Criswell, & Breese, 2011; Roberto et al., 2010; Zhu & Lovinger, 2006) . Thus, the presynaptic effects of ethanol appear to strongly contribute to the pro-GABAergic effects observed in vivo (Criswell & Breese, 2005; Perra et al., 2008) .
The potentiation of GABA release by forskolin, and the reduction in ethanol potentiation by an AC inhibitor, also fit with a growing literature implicating this signaling molecule in presynaptic ethanol actions at GABAergic synapses (Das, Pany, Rahman, & Slater, 2009; Kelm et al., 2008; Yoshimura, Pearson, Kadota, & Gonzalez, 2006) . Pharmacological and gene knockout data indicate that intact AC/PKA signaling is necessary for acute ethanol-induced increases in GABA release (Kelm et al., 2008; Roberto et al., 2010) . This may be related to the ability of ethanol to stimulate some AC subtypes (Luthin & Tabakoff, 1984; Rabin & Molinoff, 1981; Tabakoff et al., 2001 ). It will be important to determine the pattern of AC subtype expression at ethanol-sensitive GABAergic synapses.
Considerable evidence suggests involvement of the eCB/CB1 signaling system in the pharmacological (Perra et al., 2008; Roberto et al., 2010) and behavioral actions of ethanol, including reward, preference, and self-administration (Arnone et al., 1997; Colombo et al., 2005 Colombo et al., , 2007 Hungund & Basavarajappa, 2004; Manzanares et al., 2005; Thanos et al., 2005) . The specific role in alcoholrelated behaviors of eCBs and CB1 in the BLA has not been investigated. However, the BLA has important roles in value coding, and evidence indicates important roles for BLA GABAergic transmission in control of anxiety (Bueno, Zangrossi, & Viana, 2005; Diaz, Chappell, et al., 2011; Gonzalez, Andrews, & File, 1996; Pesold & Treit, 1995; Sanders & Shekhar, 1995; Silberman, Ariwodola, Chappell, Yorgason, & Weiner, 2010) . Acute ethanol intoxication is generally associated with decreased anxiety, while withdrawal after chronic exposure can be anxiogenic (Heilig, Egli, Crabbe, & Becker, 2010; Kliethermes, 2005) . Treatments that reduce activation of BLA projection neurons reduce withdrawal-induced increases in anxiety (Läck et al., 2007 (Läck et al., , 2009 . Furthermore, CB1 receptors regulate affective behavior and responses to stressful stimuli via mechanisms involving the BLA (Brzózka, Fischer, Falkai, & Havemann-Reinecke, 2011; Martin, Ledent, Parmentier, Maldonado, & Valverde, 2002) , and these neural actions are likely to be altered by ethanol. Altering inhibitory input to BLA projection neurons will influence output from this important nucleus, and thus it will be interesting to see whether manipulation of BLA GABAergic inhibition by eCBs or CB1 alters withdrawal-induced anxiety.
